- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02241317
Diabetes Mellitus at the University Medical Center of Mannheim (DmUMM)
Effects of Training of Medical Staff on the Outcome of In-Patients With Diabetes Mellitus on Regular Wards
Study Overview
Status
Conditions
Detailed Description
The prevalence of Diabetes in in-patients is about 32% and therefore exceeds significantly the prevalence in general population.
In most cases Diabetes is only a secondary diagnosis the medical staff has to deal with daily. The diagnosis which leads to hospital admission and the often multiple comorbidities complicate the metabolic control. Blood sugar imbalances present an additional risk for these patients and increase in-hospital mortality, length of hospital stay and general complications as nosocomial infections.
To improve hospital care for diabetics the Endocrine Society and the American College of Physicians published new guidelines on blood glucose management for non-ICU wards. Primarily they contain recommendations for blood glucose target range and standards to improve inpatient hospital care like standard operating procedures for blood glucose monitoring as well as hyper- and hypoglycaemic disturbances through to discharge management.
We developed a training concept for health care professionals (nursing and medical staff), according to the current guidelines on treatment of in-patients with Diabetes. Primary endpoint is the change in hypoglycaemia rates comparing data before and after the training. Hereby we can derive the effects of staff training on the quality of health care in this patient population.
So far there was only one comparable study published which showed a significant improvement of treatment quality by reducing hypoglycaemia rates considerably . The results of this study cannot be transferred due to substantial structural differences. More over there are no national diabetes management guidelines for inpatient treatment in Germany.
The following data will be collected:
- Anthropometric data (Age, Sex, Bodyweight, Height)
- Diagnosis
- POCT blood glucose values
- Other laboratory values
- Length of hospital stay
This study conforms to the requirements of the Declaration of Helsinki, Revision of 1996.
Study Type
Enrollment (Anticipated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diabetes mellitus
Exclusion Criteria:
- Age <18 years
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Hypoglycaemia
Time Frame: 2013-2015 (two years)
|
2013-2015 (two years)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alexander Lammert, Dr. med., Universitätsmedizin Mannheim
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014-831R-MA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.